Tuberculosis, the world’s leading infectious killer, may have finally met its match. Two new drug therapies may be able to cure all forms of tuberculosis – even the ones most difficult to treat.
“We will have something to offer every single patient,” says Mel Spigelman, president ...
Acting Deputy Chief of Mission of the United States to Tajikistan Lucy Jilka yesterday (January 31) joined the First Deputy Minister of Health and Social Protection of Population of Tajikistan Saida Umarzoda, national health leadership, physicians, TB doctors, and stakeholders to celebrate the introduction of ...
In an effort to improve the international response to combatting multidrug-resistant TB, MPP and Johns Hopkins University sign licensing agreement for investigational treatment sutezolid
Geneva, 25 January 2017 — The Medicines Patent Pool today announced that it has signed a licence with Johns Hopkins University ...
A pioneering new clinical trial aiming to find a radically improved course of treatment for drug-resistant tuberculosis (TB) began on 17th January 2017, when the first patient took the first pill in Uzbekistan.
The phase II/III trial, called TB PRACTECAL, aims to find a treatment regime ...
From the first days of annexation of Crimea and launch of the military operation in the east of Ukraine, Alliance for Public Health (hereinafter – Alliance) defined that one of its priorities was support of HIV, tuberculosis, viral hepatitis prevention and treatment programs, as well ...
Washington, DC – January 13, 2017 – A clever new tuberculosis vaccine has shown promise in trials in mice. If it succeeds, it will be the first new TB vaccine in a century. With the rise of multidrug resistant tuberculosis, the difficulty of curing the ...
Dramatic decrease of funding from donors for HIV and TB responses and inability or unwillingness of governments to finance such programs has devastating effects on key affected populations (KAPs) in middle-income countries (MICs) – sex workers, men who have sex with men, people who use ...
Mircea, a former miner in his fifties, spent the last four years of his life succumbing to Extensively Drug Resistant Tuberculosis (XDR-TB) at the Pines Tuberculosis Sanatorium, which is located high on a mountain. After seven years with this otherwise curable illness, his family wanted ...